Skip to Content

AHI M21 (Methyldopa 125 mg)

Pill imprint AHI M21 has been identified as Methyldopa 125 mg.

Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Methyldopa
Imprint:
AHI M21
Strength:
125 mg
Color:
Peach
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Accord Healthcare Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide